Does Na+/Ca2+ Exchanger, NCX, Represent a New Druggable Target in Stroke Intervention?

Translational Stroke Research

Volumn 5, Issue 1, 2014, Pages 145-155

  Pignataro, Giuseppe ^a   Sirabella, Rossana ^b   Anzilotti, Serenella ^b   Di Renzo, Gianfranco ^a   Annunziato, Lucio ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

Brain ischemia; Ionic homeostasis; Ionic transporters; NCX; Sodium calcium exchanger; Stroke

Indexed keywords

SODIUM CALCIUM EXCHANGE PROTEIN;

ARTICLE; BRAIN; BRAIN HYPOXIA; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CEREBROVASCULAR ACCIDENT; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE SILENCING; HUMAN; IN VITRO STUDY; MAMMAL; NCX GENE; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CALCIUM EXCHANGE; TRANSGENIC ORGANISM;

ANIMALS; BRAIN; BRAIN ISCHEMIA; GENE TARGETING; HUMANS; MICE; RATS; SODIUM-CALCIUM EXCHANGER; STROKE;

EID: 84893793754     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0308-8     Document Type: Article

References (84)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371: 1612-23.
2. Annunziato L, Cataldi M, Pignataro G, Secondo A, Molinaro P. Glutamate-independent calcium toxicity: introduction. Stroke. 2007;38: 661-4.
3. Annunziato L, Pignataro G, Boscia F, Sirabella R, Formisano L, Saggese M, et al. Di Renzo GF: ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia. Ann N Y Acad Sci. 2007;1099: 413-26.
4. Olney JW. Status of monosodium glutamate revisited. Am J Clin Nutr. 1973;26: 683-5.
5. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22: 391-7.
6. + channels. Annu Rev Physiol. 1997;59: 23-42.
7. 2+ exchanger: from molecular biology to therapeutic perspectives. Pharmacol Rev. 2004;56: 633-54.
8. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1: 623-34.
9. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988;11: 465-9.
10. Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988;8: 185-96.
11. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79: 1431-568.
12. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev. 1999;79: 763-854.
13. Reeves JP, Hale CC. The stoichiometry of the cardiac sodium-calcium exchange system. J Biol Chem. 1984;259: 7733-9.
14. 2+ exchanger. Am J Physiol Cell Physiol. 2004;287: C1167-1172.
15. 2+ exchanger. Nature. 2004;427: 544-8.
16. 2+ exchanger. Science. 1990;250: 562-5.
17. 2+ exchanger. J Biol Chem. 1994;269: 17434-9.
18. 2+ exchanger, NCX3. J Biol Chem. 1996;271: 24914-21.
19. 2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am J Physiol. 1997;272: C1250-1261.
20. 2+ exchanger. J Biol Chem. 1999;274: 910-7.
21. Philipson KD, Nicoll DA. Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol. 2000;62: 111-33.
22. 2+ exchanger isoforms. J Biol Chem. 1994;269: 14849-52.
23. Endo H, Nito C, Kamada H, Yu F, Chan PH. Akt/GSK3beta survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats. Stroke. 2006;37: 2140-6.
24. 2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system. Ann N Y Acad Sci. 2002;976: 394-404.
25. Madison DV, Schuman EM. LTP, post or pre? A look at the evidence for the locus of long-term potentiation. New Biol. 1991;3: 549-57.
26. 2+ exchanger in vascular smooth muscle, and in neurons and astrocytes. Ann N Y Acad Sci. 1996;779: 318-35.
27. 2+ exchange mechanism. Brain Res. 1985;338: 384-6.
28. ++ exchange by amiloride. J Pharmacol Exp Ther. 1988;246: 689-94.
29. Taglialatela M, Amoroso S, Kaparos G, Maurano F, Di Renzo GF, Annunziato L. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+, K + -adenosine triphosphatase pump by ouabain. J Pharmacol Exp Ther. 1988;246: 682-8.
30. ++ exchanger in central nerve endings: the relationship between its pharmacological blockade and dopamine release from tuberoinfundibular hypothalamic neurons. Neurochem Int. 1992;20(Suppl): 95S-9S.
31. 2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons. Mol Pharmacol. 1990;38: 393-400.
32. 2+ channels. Mol Pharmacol. 1990;38: 385-92.
33. Magyar K, Nguyen TT, Torok TL. Toth PT: [3H]noradrenaline release from rabbit pulmonary artery: sodium-pump-dependent sodium-calcium exchange. J Physiol. 1987;393: 29-42.
34. + antiporters in prolactin release from anterior pituitary cells in primary culture. Eur J Pharmacol. 1995;294: 11-5.
35. 2+)-exchange. Neuropharmacology. 2001;40: 345-51.
36. 2+ exchanger in histaminergic neurones. J Neurochem. 2003;87: 657-64.
37. 2+ exchanger 2. Neuron. 2003;38: 965-76.
38. Sokolow S, Manto M, Gailly P, Molgo J, Vandebrouck C, Vanderwinden JM, et al. Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3. J Clin Invest. 2004;113: 265-73.
39. 2+) exchanger in brain ischemia and in spatial learning and memory deficits. Adv Exp Med Biol. 2013;961: 213-22.
40. 2+ exchanger (NCX3) knock-out mice display an impairment in hippocampal long-term potentiation and spatial learning and memory. J Neurosci. 2011;31: 7312-21.
41. Kintner DB, Wang Y, Sun D. Role of membrane ion transport proteins in cerebral ischemic damage. Front Biosci. 2007;12: 762-70.
42. Boscia F, Gala R, Pannaccione A, Secondo A, Scorziello A, Di Renzo G, et al. NCX1 expression and functional activity increase in microglia invading the infarct core. Stroke. 2009;40: 3608-17.
43. 2+ exchanger protects C6 glioma cells during chemical hypoxia. Br J Pharmacol. 1997;121: 303-9.
44. 2+ exchanger in C6 glioma cells. J Neurochem. 2000;74: 1505-13.
45. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther. 2001;298: 249-56.
46. 2+ exchanger in reperfusion-induced delayed cell death of cultured rat astrocytes. Eur J Neurosci. 1996;8: 951-8.
47. 2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res. 1991;548: 322-5.
48. +). Mol Pharmacol. 1999;56: 619-32.
49. + in NMDA excitotoxicity in glucose-deprived and depolarized cerebellar granule cells. J Neurochem. 2002;81: 379-89.
50. 2+ exchange inhibitor KB-R7943 protects CA1 neurons in rat hippocampal slices against hypoxic/hypoglycemic injury. Neuropharmacology. 1999;38: 319-21.
51. Stys PK, Lopachin RM. Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience. 1998;82: 21-32.
52. Stys PK, Ransom BR, Waxman SG, Davis PK. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A. 1990;87: 4212-6.
53. 2+) exchange in spinal cord white matter injury at physiological temperature. J Neurophysiol. 2000;84: 1116-9.
54. Wolf JA, Stys PK, Lusardi T, Meaney D, Smith DH. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci. 2001;21: 1923-30.
55. Annunziato L, Pannaccione A, Cataldi M, Secondo A, Castaldo P, Di Renzo G, et al. Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? Neurobiol Aging. 2002;23: 819-34.
56. 2+ regulation. Mech Ageing Dev. 1984;25: 215-25.
57. 2+ influx or efflux pathway. Biochim Biophys Acta. 1992;1107: 175-8.
58. 2+ handling systems and neuronal aging. Ann N Y Acad Sci. 1989;568: 89-94.
59. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J Neurochem. 1994;62: 372-5.
60. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 1993;16: 409-14.
61. 2+ influx. J Neurochem. 1995;65: 1061-8.
62. Wu A, Derrico CA, Hatem L, Colvin RA. Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles. Neuroscience. 1997;80: 675-84.
63. Pannaccione A, Secondo A, Molinaro P, D'Avanzo C, Cantile M, Esposito A, et al. A new concept: Abeta1-42 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death. J Neurosci. 2012;32: 10609-17.
64. 2+ exchanger gene expression in the ischemic core, periinfarct area, and intact brain regions. J Cereb Blood Flow Metab. 2006;26: 502-17.
65. Pignataro G, Gala R, Cuomo O, Tortiglione A, Giaccio L, Castaldo P, et al. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke. 2004;35: 2566-70.
66. 2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage. J Neurosci. 2008;28: 1179-84.
67. 2+ exchanger (NCX1, NCX2, NCX3). Am J Physiol. 1998;274: C415-423.
68. Secondo A, Staiano RI, Scorziello A, Sirabella R, Boscia F, Adornetto A, et al. BHK cells transfected with NCX3 are more resistant to hypoxia followed by reoxygenation than those transfected with NCX1 and NCX2: possible relationship with mitochondrial membrane potential. Cell Calcium. 2007;42: 521-35.
69. Condrescu M, Gardner JP, Chernaya G, Aceto JF, Kroupis C, Reeves JP. ATP-dependent regulation of sodium-calcium exchange in Chinese hamster ovary cells transfected with the bovine cardiac sodium-calcium exchanger. J Biol Chem. 1995;270: 9137-46.
70. 2+ refilling into endoplasmic reticulum in cortical neurons. Stroke. 2009;40: 922-9.
71. 2+ exchanger in cerebral ischemia induced by middle cerebral artery occlusion in male rats. Neuropharmacology. 2004;46: 439-48.
72. 2+ exchanger activity, effectively protects against stroke damage. Mol Pharmacol. 2012;83: 142-56.
73. Formisano L, Guida N, Valsecchi V, Pignataro G, Vinciguerra A, Pannaccione A, et al. NCX1 is a new rest target gene: role in cerebral ischemia. Neurobiol Dis. 2013;50: 76-85.
74. 2+ exchanger isoform 1. Ann N Y Acad Sci. 2007;1099: 292-305.
75. 2+ exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway. Mol Pharmacol. 2008;73: 727-37.
76. Pignataro G, Cuomo O, Esposito E, Sirabella R, Di Renzo G, Annunziato L. ASIC1a contributes to neuroprotection elicited by ischemic preconditioning and postconditioning. Int J Physiol Pathophysiol Pharmacol. 2011;3: 1-8.
77. Pignataro G, Boscia F, Esposito E, Sirabella R, Cuomo O, Vinciguerra A, et al. NCX1 and NCX3: two new effectors of delayed preconditioning in brain ischemia. Neurobiol Dis. 2012;45: 616-23.
78. Pignataro G, Cuomo O, Vinciguerra A, Sirabella R, Esposito E, Boscia F, et al. NCX as a key player in the neuroprotection exerted by ischemic preconditioning and postconditioning. Adv Exp Med Biol. 2013;961: 223-40.
79. 2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning. J Cereb Blood Flow Metab. 2011;31: 362-70.
80. Valsecchi V, Pignataro G, Del Prete A, Sirabella R, Matrone C, Boscia F, et al. NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke. 2011;42: 754-63.
81. Valsecchi V, Pignataro G, Sirabella R, Matrone C, Boscia F, Scorziello A, et al. Transcriptional regulation of ncx1 gene in the brain. Adv Exp Med Biol. 2013;961: 137-45.
82. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003;26: 248-54.
83. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006;7: 437-48.
84. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab. 2002;22: 1283-96.